Title | NPY signaling inhibits extended amygdala CRF neurons to suppress binge alcohol drinking |
Publication Type | Journal Article |
Year of Publication | 2015 |
Authors | Pleil KE, Rinker JA, Lowery-Gionta EG, Mazzone CM, McCall NM, Kendra AM, Olson DP, Lowell BB, Grant KA, Thiele TE, Kash TL |
Journal | Nat Neurosci |
Volume | 18 |
Issue | 4 |
Pagination | 545-52 |
Date Published | 2015 Apr |
ISSN | 1546-1726 |
Keywords | Animals, Behavior, Animal, Binge Drinking, Circadian Rhythm, Corticotropin-Releasing Hormone, Disease Models, Animal, Macaca mulatta, Male, Mice, Mice, Inbred C57BL, Neural Inhibition, Neuropeptide Y, Receptors, Neuropeptide Y, Septal Nuclei, Signal Transduction |
Abstract | Binge alcohol drinking is a tremendous public health problem because it leads to the development of numerous pathologies, including alcohol abuse and anxiety. It is thought to do so by hijacking brain systems that regulate stress and reward, including neuropeptide Y (NPY) and corticotropin-releasing factor (CRF). The central actions of NPY and CRF have opposing functions in the regulation of emotional and reward-seeking behaviors; thus, dysfunctional interactions between these peptidergic systems could be involved in the development of these pathologies. We used converging physiological, pharmacological and chemogenetic approaches to identify a precise neural mechanism in the bed nucleus of the stria terminalis (BNST), a limbic brain region involved in pathological reward and anxiety behaviors, underlying the interactions between NPY and CRF in the regulation of binge alcohol drinking in both mice and monkeys. We found that NPY Y1 receptor (Y1R) activation in the BNST suppressed binge alcohol drinking by enhancing inhibitory synaptic transmission specifically in CRF neurons via a previously unknown Gi-mediated, PKA-dependent postsynaptic mechanism. Furthermore, chronic alcohol drinking led to persistent alterations in Y1R function in the BNST of both mice and monkeys, highlighting the enduring, conserved nature of this effect across mammalian species. Together, these data provide both a cellular locus and signaling framework for the development of new therapeutics for treatment of neuropsychiatric diseases, including alcohol use disorders. |
DOI | 10.1038/nn.3972 |
Alternate Journal | Nat Neurosci |
PubMed ID | 25751534 |
PubMed Central ID | PMC4376619 |
Grant List | AA109431 / AA / NIAAA NIH HHS / United States AA020911 / AA / NIAAA NIH HHS / United States P30 DK046200 / DK / NIDDK NIH HHS / United States K08 DK071561 / DK / NIDDK NIH HHS / United States AA013541 / AA / NIAAA NIH HHS / United States AA013573 / AA / NIAAA NIH HHS / United States P30 NS045892 / NS / NINDS NIH HHS / United States AA019454 / AA / NIAAA NIH HHS / United States R01 DK096010 / DK / NIDDK NIH HHS / United States AA022048 / AA / NIAAA NIH HHS / United States T32 GM008322 / GM / NIGMS NIH HHS / United States R01 DK075632 / DK / NIDDK NIH HHS / United States R01 DK089044 / DK / NIDDK NIH HHS / United States AA011605 / AA / NIAAA NIH HHS / United States F32 AA021043 / AA / NIAAA NIH HHS / United States AA021043 / AA / NIAAA NIH HHS / United States DK057521 / DK / NIDDK NIH HHS / United States DK075632 / DK / NIDDK NIH HHS / United States P30 DK020572 / DK / NIDDK NIH HHS / United States DK046200 / DK / NIDDK NIH HHS / United States P30 DK057521 / DK / NIDDK NIH HHS / United States R01 AA019454 / AA / NIAAA NIH HHS / United States P50 AA011605 / AA / NIAAA NIH HHS / United States T32 DA007244 / DA / NIDA NIH HHS / United States U01 AA020911 / AA / NIAAA NIH HHS / United States R37 AA013573 / AA / NIAAA NIH HHS / United States DK071561 / DK / NIDDK NIH HHS / United States DK096010 / DK / NIDDK NIH HHS / United States R01 AA013573 / AA / NIAAA NIH HHS / United States P60 AA011605 / AA / NIAAA NIH HHS / United States R01 AA022048 / AA / NIAAA NIH HHS / United States |